Realtime AI News
DeepSeek 新模型登顶开源模型榜首；国内 55% 算力用于视频和短剧？豆包发言人辟谣；微信发起公众号小说改编微短剧激励｜极客早知道 极客公园
DeepSeek 新模型登顶开源模型榜首；国内 55% 算力用于视频和短剧？豆包发言人辟谣；微信发起公众号小说改编微短剧激励｜极客早知道 极客公园. DeepSeek 新模型登顶开源模型榜首；国内 55% 算力用于视频和短剧？豆包发言人辟谣；微信发起公众号小说改编微短剧激励｜极客早知道 极客公园
According to news.google.com, DeepSeek 新模型登顶开源模型榜首；国内 55% 算力用于视频和短剧？豆包发言人辟谣；微信发起公众号小说改编微短剧激励｜极客早知道 极客公园.
DeepSeek 新模型登顶开源模型榜首；国内 55% 算力用于视频和短剧？豆包发言人辟谣；微信发起公众号小说改编微短剧激励｜极客早知道 极客公园
The signal matters because AI capabilities are moving into more specific product, infrastructure, or business workflows.
The next things to watch are availability, pricing or access limits, and whether the update creates a measurable workflow change for builders or enterprise users.
Why it matters
This update reflects the continued movement of AI capabilities into concrete product, platform, and industry contexts.
Nearby Updates
All10/20, 09:09
Claude新模型曝光！能跳出思维定势，修Bug治标又治本
Claude新模型曝光！能跳出思维定势，修Bug治标又治本. OpenAI只掏出一个6.1 Terra…
10/20, 09:27
New York's Mamdani says an AI takeover is not inevitable and urges residents to push back
New York Mayor Zohran Mamdani told a Manhattan audience on Monday night that AI's spread is not inevitable and that residents should demand accountability from AI companies. Speaking at the People's AI Assembly with actor Ilana Glazer, he criticized federal inaction on AI regulation and pointed to his own city-level school ban and AI-disclosure rules for housing listings.
10/20, 10:04
DeepSeek and MiniMax Ship New Flash Models Within 72 Hours
DeepSeek and MiniMax each released new Flash-series models within 72 hours of one another, according to a 36Kr report that frames the pair as challengers to flagship-tier generative AI. The compressed rollout window puts fresh attention on whether lighter product lines can now close the gap with top-end models.
10/20, 08:00
OpenAI Acquires Orchestra Bio to Bring AI Operations Into Life Sciences R&D
OpenAI is acquiring Orchestra Bio to bring AI-powered operations into life sciences research and development, according to the company's announcement. The stated goal is to help biopharma teams accelerate drug development and move new treatments forward.